Brief: Immucell Corp - Sales During First Quarter Ended March 31, 2022 Increased By 46% To $6.0 Million Compared To The Same Period Of The Prior Year

ImmuCell

11/04/2022 20:14

April 11 (Reuters) - ImmuCell Corp  ICCC.O :
    * IMMUCELL CORP - SALES DURING FIRST QUARTER ENDED MARCH 31,
2022
INCREASED BY 46% TO $6.0 MILLION COMPARED TO THE SAME PERIOD OF
THE PRIOR YEAR
    * IMMUCELL CORP - INITIATED ADDITIONAL INVESTMENT TO FURTHER
INCREASE ITS ANNUAL FIRST DEFENSE MANUFACTURING CAPACITY TO
ABOUT $35 MILLION BY END OF 2022
    * IMMUCELL CORP - EXPECT A RESPONSE FROM FDA DURING Q3 TO
SUBMISSION OF  FINAL TECHNICAL SECTION REQUIRED TO COMPLETE NEW
ANIMAL DRUG APPLICATION
    * IMMUCELL CORP - 2022 Q1 ANNUALIZED MANUFACTURING OUTPUT
REACHED
$23.8 MILLION

Source text for Eikon:  ID: 
Further company coverage:  ICCC.O 

 ((Reuters.Briefs@thomsonreuters.com;))